Cancer_Cell_Biology_Research_Program News
|
VUMC scientists discover key step to kidney fibrosis Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Tuesday, November 21st, 2023 |
|
Ken Lau named 2023 Stanley Cohen Innovation Fund Awardee Ken Lau, professor of cell and developmental biology, has been selected to receive a one-year research award from the Stanley Cohen Innovation Fund. Tuesday, November 7th, 2023 |
|
New dean of Basic Sciences aims to take Vanderbilt to the next level in biomedical research, drug discovery Whether working on dynamic discoveries in the lab, connecting with students and faculty or pursuing his passion for nature photography, acclaimed biomedical researcher John Kuriyan is inspired by his recent move to join Vanderbilt as the new dean of the School of Medicine Basic Sciences and Distinguished University Professor. Monday, April 3rd, 2023 |
|
New screening method could pave the way for future cancer drug discoveries New screening method could pave the way for future cancer drug discoveries Tuesday, January 17th, 2023 |
|
VUMC researchers upend dogma about vasopressin production Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney. Thursday, January 5th, 2023 |
